A

Amneal Intermediate Inc
NASDAQ:AMRX

Watchlist Manager
Amneal Intermediate Inc
NASDAQ:AMRX
Watchlist
Price: 8.46 USD -2.76% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Amneal Intermediate Inc?
Write Note

Amneal Intermediate Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amneal Intermediate Inc
Income from Continuing Operations Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
A
Amneal Intermediate Inc
NASDAQ:AMRX
Income from Continuing Operations
-$48.7m
CAGR 3-Years
-6%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Income from Continuing Operations
$14.8B
CAGR 3-Years
-6%
CAGR 5-Years
1%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Income from Continuing Operations
-$6.5B
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Income from Continuing Operations
-$2.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Income from Continuing Operations
$13.8B
CAGR 3-Years
55%
CAGR 5-Years
7%
CAGR 10-Years
9%
Eli Lilly and Co
NYSE:LLY
Income from Continuing Operations
$7.3B
CAGR 3-Years
7%
CAGR 5-Years
11%
CAGR 10-Years
8%

See Also

What is Amneal Intermediate Inc's Income from Continuing Operations?
Income from Continuing Operations
-48.7m USD

Based on the financial report for Dec 31, 2023, Amneal Intermediate Inc's Income from Continuing Operations amounts to -48.7m USD.

What is Amneal Intermediate Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
25%

Over the last year, the Income from Continuing Operations growth was 81%. The average annual Income from Continuing Operations growth rates for Amneal Intermediate Inc have been -6% over the past three years , 25% over the past five years .

Back to Top